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The human DNA damage response (DDR) triggers profound changes in gene expression, whose nature and
regulation remain uncertain. Although certain micro-(mi)RNA species including miR34, miR-18, miR-16 and miR-143
have been implicated in the DDR, there is as yet no comprehensive description of genome-wide changes in the
expression of miRNAs triggered by DNA breakage in human cells. We have used next-generation sequencing (NGS),
combined with rigorous integrative computational analyses, to describe genome-wide changes in the expression of
miRNAs during the human DDR. The changes affect 150 of 1523 miRNAs known in miRBase v18 from 4–24 h after the
induction of DNA breakage, in cell-type dependent patterns. The regulatory regions of the most-highly regulated
miRNA species are enriched in conserved binding sites for p53. Indeed, genome-wide changes in miRNA expression dur-
ing the DDR are markedly altered in TP53-/- cells compared to otherwise isogenic controls. The expression levels of cer-
tain damage-induced, p53-regulated miRNAs in cancer samples correlate with patient survival. Our work reveals
genome-wide and cell type-speciﬁc alterations in miRNA expression during the human DDR, which are regulated by the
tumor suppressor protein p53. These ﬁndings provide a genomic resource to identify new molecules and mechanisms
involved in the DDR, and to examine their role in tumor suppression and the clinical outcome of cancer patients.
Introduction
The response of human cells to DNA damage (DDR) is essen-
tial for the maintenance of genome stability. The DDR not only
involves well-characterized changes in protein localization or
modification, but also profound changes in gene expression that
are less well understood. Thus, DDR signaling alters gene
transcription via a plethora of transcription factors including
NF-kB 1,2, p53,3 AP-1,4 E2F1 5 or FoxM1.6 Moreover, there is
evidence that certain small non-coding RNAs such as micro (mi)
RNAs can also modulate changes in gene expression during the
DDR. In particular, members of the miR-34 family are induced
by DNA damage to regulate the expression of proteins involved
in cell cycle progression or cell death.7,8,9,10,11 Other miRNA
species including miR-182,12 miR-16 and miR-14313,14 have
also been implicated. However, there is as yet no comprehensive
description of genome-wide changes in the expression of miR-
NAs triggered by DNA breakage in human cells.
We have addressed this issue using next-generation sequenc-
ing (NGS). Experience in the use of NGS to document changes
in small, non-coding RNA expression during a biological process
is still limited.15,16 Although the method has the theoretical
advantages of high sensitivity, wide dynamic range and the capac-
ity to detect alterations in known as well as hitherto undocu-
mented small RNA species,17 robust methodologies for its
deployment in this setting are still being established.
Here, we provide a methodological blueprint for the charac-
terization by NGS of miRNA expression in human cells via a
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systematic pipeline of bioinformatics analyzes. We provide a new
resource and database describing these changes during the DDR,
which not only can be used to compare changes in the human
miRNAome during different biological processes, but also can be
mined to reveal new molecules and mechanisms underlying the
DDR. Our findings reveal a biological role for the tumor sup-
pressor p53 in shaping genome-wide changes in miRNA expres-
sion during the DDR in a cell-type specific manner.
Results
Genome-wide changes in the expression of small non-coding
RNAs are induced by DNA damage in human cells
Ionizing radiation (IR) induces several different DNA lesions,
including widespread DNA breakage in the form of double-
stranded DNA breaks (DSBs), besides single-stranded gaps and
nucleotide alterations.18 To characterize changes in small non-cod-
ing RNA expression during the DDR, we first exposed 2 human
cell lines, MCF10A19 and HCT116,20 to a dose of 5Gy, estimated
to create on average 200 DSBs per cell.21 Cells were harvested at
0 h (i.e., untreated cells) or at 4 h and 24 h following exposure
(Fig. 1A). Both MCF10A and HCT116 cell lines exhibited a simi-
lar, robust response to IR exposure, evidenced by the phosphoryla-
tion of ATM kinase on Ser1981, induction of p53, and its
phosphorylation on Ser15 (Fig. 1B). Total RNAs extracted from
the IR-exposed cells were size-selected for small RNA molecules
corresponding to 18-30nt, before cDNA library generation for
NGS using the Illumina DGE small RNA prep kit v1.5 (Fig. 1A).
Capillary-chip electrophoresis was used to confirm the size, quality
and concentration of the cDNA libraries before NGS.
The raw reads were processed using a bioinformatics pipeline
presented in Fig. S1A and mapped to the human genome. The
mapped reads were categorized into different RNA species on the
basis of their sequence (Methods). In particular, 1211 miRNAs
among the mapped reads were identified as known species in
miRBase v1822 using BLAST,23 whereas 308 putative new
miRNA species were predicted using MIReNA v2.24
Known miRNAs account for the vast majority of small non-
coding RNA species detected in our experimental approach.
Approximately 98% of the 17»22 £ 106 mapped reads in each of
the 3 samples prepared from MCF10A cells corresponded to
known miRNAs (Fig. 2A), as did a similar fraction of the 13»15
£ 106 mapped reads detected in the corresponding samples from
HCT116 cells (Fig. 2B). A very small number (0.28% on average)
of the mapped reads in both cell types were predicted to encode
putative new miRNA species (Fig. 2C and D). While our method
of sample preparation for NGS is designed to extract only small
RNA species of length 18-30nt corresponding to miRNAs, we
could still detect changes in the expression of certain other small
non-coding RNA molecules such as tRNAs (»0.42%) and small
nucleolar (sno)RNAs (»0.34%) (Fig. 2C and D), including
ACA45, a snoRNA thought to exhibit miRNA-like functions.25
However, these changes affect only a small fraction of these small,
non-coding RNAs, and given the technical limitations of our sam-
pling procedure, do not capture the majority of such events.
DDR-induced changes in the expression of known miRNAs
exhibit cell-type dependent patterns
To identify DDR-induced changes in the expression of
known miRNAs, we first compared normalized read counts for
the identified miRNA species at 4 h and 24 h after IR to
untreated control cells at 0 h. The significance of the differential
expression for each miRNA was calculated on count data using a
binomial approximation to Fisher’s exact test.26 The Fig. 3 shows
Figure 1. Experimental design for studying genome-wide changes in small non-coding RNA expression during the DDR. (A) Outline of the experimental
design. MCFA10A or HCT116 cells were treated with the 5Gy IR and harvested at each indicated time point. The 18~30 nt fraction of cellular small RNA
was isolated by gel ﬁltration. cDNA libraries were generated from this fraction using the Illumina Small RNA Sample Prep Kit before next-generation
sequencing. (B) Western blots for phosphorylated ATM (Ser1981), TP53 and phosphorylated TP53 (Ser15) in the cell lines used in these studies (MCF10A,
HCT116 and HCT116 TP53-/-) after DNA damage. Cells exposed to 5Gy IR were harvested at 4 and 24 h after exposure, before extract preparation for blot-
ting. UT refers to untreated cells.
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the log2 fold change values (M) for each species plotted on the y-
axis vs. the absolute number of reads (A) on the x-axis. We
focused on DDR-induced changes in the expression of miRNAs
with corrected p-value < 0.05, excluding any miRNAs of low
abundance with A < 5 (i.e., absolute read count <32) and any
miRNAs with only a low change in expression with |M| < 0.75
(i.e., 0.59 < FC < 1.68) when compared with the control.
Eighty-eight and 93 miRNA species fulfil these criteria at 4 h or
24 h after the exposure to DNA damage of MCF10A and
HCT116 cells, respectively. Overall, we found 150 miRNAs
whose expression is significantly altered during the DDR, includ-
ing 31 miRNAs expressed in both MCF10A and HCT116 cell
lines (Fig. 4A). For convenience, we refer henceforth to these
DDR-regulated species as ‘DDR miRNAs’.
Several patterns of altered expression were observed in
MCF10A cells (Fig. 4B), ranging from simple, sustained induction
or repression of expression at 4 h and 24 h, to more complex pat-
terns. We classified the patterns of expression by their kinetics into
4 representative clusters, A-D (Fig. 4C). Clusters A and B contain
miRNAs whose expression was significantly induced: 23 were max-
imally induced at 4 h (cluster A) and 24 were maximally induced
at 24 h (cluster B). Clusters C and D contain repressed miRNAs,
whose expression significantly decreased after DNA damage. Clus-
ter C, which included only 4 miRNAs, exhibited a rapid repression
maximal at 4 h, whereas cluster D, including 31 miRNAs, exhib-
ited baseline expression at 4 h with evident repression at 24 h.
Similar expression patterns
are also observed for the
DDR miRNAs in HCT116
(Fig. 5). However, the com-
position of the similarly-regu-
lated clusters is distinct,
revealing cell type-specific dif-
ferences. For example, cluster
A in HCT116 corresponds to
51 miRNAs induced mainly
at 24 h, but only 6 of them
(miRs 125a-5p, 744-3p,
125b-5p, 99b-5p, 152 and
1947411_x4) are shared with
MCF10A. Similarly, cluster B
in HCT116 corresponds to
only 3 miRNAs induced
mainly at 4 h but none of
them are shared with
MCF10A. Intriguingly, 7
DDR miRNAs (miRs 1, 34a-
5p, let-7a-3p, 365b-3p, 365a-
3p, 423-5p, 3184-3p) are
induced at 24 h in HCT116
(cluster A) and at 4 h in
MCF10A (cluster B)
(Figs. 4B and 5A). Indeed, as
a general trend, the DDR
miRNAs in HCT116 are not
as highly induced at 4 h when
compared with MCF10A, but instead, are more highly induced
at 24 h (Chi square p-value D 0.009534). MA plot analysis also
shows that a larger number of miRNAs were induced at 24 h
than at 4 h in HCT116 (Fig. 3C and D), whereas similar num-
bers of miRNAs were induced in MCF10A (Fig. 3A and B).
These observations suggest cell-type dependent differences in the
kinetics of the induction of DDR miRNAs, with a slower
response evident in HCT116 cells.
To further characterize the induced miRNAs, we focused on
the most robustly-induced miRNAs after DNA damage using
the following filtering criteria: (a) the miRNAs must show a con-
sistent induction at 4 h and 24 h, (b) the fold change at 4 h or
24 h should be higher than 0.75 (log2 value), (c) miRNAs should
be significantly induced in both cell lines and/or in 2 experimen-
tal replicates. We did not include microRNA isoforms,27 which
are mature microRNA isoforms that have an altered 30 end, in
our analysis. These criteria detected 23 DDR miRNAs
(Fig. S1B). Two additional filtering steps were performed to
remove redundant miRNAs. First, when 2 mature sequences
(eg., -5p and -3p) from the same stem loop were selected (eg.,
miR-486 and miR-139), we kept the sequence showing the best
read coverage (here the -5p fragment) on the premise that it
should correspond to the functional species of the stem loop; this
step discarded only 2 DNA-damage responsive miRNAs corre-
sponding to star sequences (miR-139-3p, miR-486-3p). Second,
when the mature sequences were identical, we selected only one
Figure 2. Classes of small non-coding RNAs responsive to DNA damage. Proportions of the different classes of small
non-coding RNAs detected after DNA damage among mapped sequence reads in MCF10A (A) and in HCT116 (B) are
summarized in the bar chart as the average fractions of total counts for each class. Y-axis represents the percentages
of the number of reads in different classes of small RNAs at different time points. (C) and (D) enlarge changes in the
fractions of small non-coding RNA classes excluding miRNAs. rRNA: ribosomal RNA, scRNA: small cytoplasmic RNA,
snRNA: small nuclear RNA, snoRNA: small nucleolar RNA, tRNA: transfer RNA,misc RNA:miscellaneous RNA.
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of them (eg., miR-365a-3p and
miR-365b-3p). These additional
filtering steps left us with a total
of 20 DDR miRNAs, 12 of which
were induced in MCF10A and 19
in HCT116, with 11 induced in
both cell types, 1 in MCF10A
alone, and 8 in HCT116 alone
(Table 1). These findings further
speak to the cell-type dependency
of changes in miRNA expression
noted earlier.
It has previously been reported
that NGS methods have greater
sensitivity and dynamic range
when compared to quantitative
(q)RT-PCR based assays for
miRNA expression.17 Accord-
ingly, we tested if the induction
of 15 of the 20 most highly-
induced miRNA species identi-
fied by NGS was also measurable
by qRT-PCR in MCF10A or
HCT116 cells exposed to DNA
damage. Nine distinct miRNA
species exhibited concordance in
MCF10A samples, and 7 did so
in HCT116 cells (Supplementary
material Fig. S2), consistent with
the slower kinetics and decreased
amplitude of induction in the lat-
ter cell type observed using NGS
(Figs. 4B and 5). Notably, the lack of concordance is observed
for miRNAs with low differential expression, consistent with the
lack of sensitivity of the qRT-PCR method in detecting small
changes in the expression of relatively abundant species.
We adopted the same approach to define the 10 most-
robustly repressed miRNAs after DNA damage: 9/10 were
repressed in MCF10A and 7 in HCT116, with 6 repressed in
both cell types (Fig. S1C). Interestingly, the species found spe-
cifically repressed in HCT116 alone is a new miRNA, identi-
fied as a member of the miR-1273 family using BLASTN
against miRNA stem loops annotated in the current miRBase
(similarity with hsa-mir-1273a, E-value D 6e-18). We also
found 2 members for each of the miR-376 and miR-378 fami-
lies. These observations once more distinguish cell-type spe-
cific patterns in the identity and kinetics of miRNA expression
following DNA damage.
DDR miRNAs are preferentially organized as intragenic
clusters
We also tested the distribution of genomic loci of DDR miR-
NAs against all miRNA-encoding loci in the genome (Fig. 6A).
For this analysis, each miRNA was assigned a descriptor classify-
ing it as intergenic or intragenic (ie., within the locus of a host
gene), and as single or clustered (ie., spacing <10 kb of a second
miRNA known in miRBase). Figure 6B shows the proportion of
the DDR miRNAs and for comparison, species not regulated
during the DDR (non-DDR miRNAs) in each of these catego-
ries. Distribution of DDR vs. non-DDR miRNAs across the cat-
egories was compared using the Fisher Exact Test. About twice as
many DDR miRNAs (53/145; 37%) were found within intra-
genic clustered species compared to non-DDR miRNAs (264/
1386; 19%) (pval D 2.73E-5), while the difference observed for
intergenic species was not found significant (p val D 1) (Fig. 6B
and Table S1). This suggests that miRNAs organized within clus-
ters in their host genes may be preferentially coordinated by tran-
scriptional regulation during the human DDR. However, we
observed no significant difference between miRNAs that are
DDR or non-DDR in intragenic as well as intergenic regions
(p val D 0.072 for single, p val D 1 for clustered).
p53 shapes genome-wide changes in the expression of
miRNAs after DNA damage in human cells
Next, we tested if the observed genome-wide changes in the
expression of miRNA species after DNA damage were coordi-
nated through one or more transcription factors (TFs). We first
extracted 566 annotated and curated TF-miRNA interactions
from the TransMir database,28 for all the DDR miRNAs, and
found that p53 was the most connected TF, regulating 4 of the
Figure 3.miRNA expression during the DDR in MCF10A and HCT116 cells over time. The MA plots in the pan-
els plot for each miRNA species the values of the log fold change (M) against the average abundance (A). We
chose as signiﬁcant those changes in which M  or 0.75 (horizontal dotted lines), and A  5 (vertical dotted
lines), i.e., 1.68-fold increase or decrease in differential expression (M) and a count rate of 32 (A). The MA
plot analysis shows 4 comparisons: A, MCF10A 4 h vs 0 h; B, MCF10A 24 h vs 0 h; C, HCT116 4 h vs 0 h; D,
HCT116 24 h vs 0 h. miRNAs exhibiting a statistically signiﬁcant change are color ed in red (p-value<D 0.05).
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12 connected DDR miRNAs
(miR-34a, miR-34c, miR-215,
miR-192) (Fig. 7). As the annota-
tion of the TF-miRNAs interac-
tions may not be representative of
all the potential interactions, we
proceeded to perform a more sys-
tematic analysis to evaluate the
relevance of p53 in regulating the
DDR miRNAs. We first used the
cisTarget approach to score pro-
moter sequences of all miRNAs
with p53 position-weight matrices
across 10 vertebrate genomes
(Aerts et al., PLoS ONE 2007).
Next, we tested whether the 20
most highly-induced DDR miRs
are enriched at the top of this
ranking using Gene Set Enrich-
ment Analysis (GSEA)29 (see
MATERIALS AND METH-
ODS). The result is shown in
Fig. 8.We found that the upregu-
lated miRNAs upon DDR are sig-
nificantly enriched with a
normalized enrichment score of
1.72 (nominal p-value
< 0.001 and FDR q-value D
0.002) while our positive controls
corresponding to known p53
miRNA target sets are found
enriched with a normalized
enrichment score of 2.02 (nomi-
nal p-value < 0.001 and FDR q-
value< 0.001 for the curated p53
targets) and 1.76 (nominal p-
value D 0.001 and FDR q-value
D 0.002 for the annotated TP53
targets. The GSEA analysis of the
20 most highly-induced DDR
miRNAs predicts 6 enriched
miRNAs that contribute most to
the enrichment score as direct
p53 targets, including 3 annotated
p53 targets (miR-125b-1 and
miR-34a/c), as well as 3 novel
p53 target miRNAs, namely miR-
486, miR-139, and let-7a-2
(Table 2). Interestingly, we also
found the consistently repressed
DDR miRNAs were highly
enriched in this ranking (NES D
1.20, nominal p-value D 0.230
and FDR q-value D 0.273),
essentially due to 3 well-ranked
miRNAs that are potential p53
Figure 4. Cell-type dependent patterns of miRNA expression during the DDR. (A) shows a Venn diagram com-
paring the distribution in MCF10A and/or HCT116 cells of 150 DDR-responsive miRNAs whose expression is sig-
niﬁcantly altered during the DDR by the criteria speciﬁed (1.68-fold increase or decrease in expression, count
rate of 32, and signiﬁcant in at least one of the samples (p 0.001, Fisher test)). (B) shows the heat map of
expression patterns for 88 DDR-responsive miRNAs in MCF10A cells at 4 h and 24 h after DNA damage, com-
pared to their expression at 0 h. Two technical replicates (1 and 2) were analyzed for each condition. Each row
represents a speciﬁc miRNA species. miRNAs were clustered by the pattern of the expression into clusters A–D.
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targets (miR-20a, miR-1273a and miR-374a). The repressed DDR
miRNA set gives lower enrichment than the induced set, whereas
the merged set gives an intermediate enrichment (NES D 1.64),
suggesting that p53 may play a stronger role in the transcriptional
activation of miRNAs after DNA damage rather than in their
repression.
These analyzes suggest that p53 plays an important role in
shaping genome-wide changes in miRNA expression after DNA
Figure 5. Cell-type dependent patterns of miRNA expression during the DDR. (A) shows the heat map of expression patterns for 93 DDR-responsive
miRNAs in HCT116 cells at 4 h and 24 h after DNA damage, compared to their expression at 0 h. Two technical replicates (1 and 2) were analyzed
for each condition. Each row represents a speciﬁc miRNA species. miRNAs were clustered by (B) shows the heat map of expression patterns for
93 DDR-responsive miRNAs in HCT116 cells at 4 h and 24 h after DNA damage, compared to their expression at 0 h.
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damage. We therefore used NGS and
bio-informatics analyzes to document the
scope of genome-wide changes in small,
non-coding RNA expression in the cell
line HCT116TP53-/-, an isogenic deriv-
ative of HCT116 in which TP53 has
been deleted by gene targeting.30 West-
ern blotting confirms that
HCT116TP53-/- cells still activate ATM
Ser1981 phosphorylation after DNA
damage, but no longer expresses the p53
protein (Fig. 1B). Moreover, qRT-PCR
analyzes (Fig. S3) confirm that the
expression of miRNAs belonging to the
miR-34 group, which are known to be
p53-dependent, is indeed significantly
suppressed in HCT116TP53-/- cells
when compared to HCT116 controls.
To assess our hypothesis in detail, we
investigated how p53 affects the patterns
of DDR miRNAs, which were induced or
repressedmainly at 24 h inHCT116, cor-
responding to the cluster A (51 miRNAs)
or the clusterD (22miRNAs), respectively
(Fig. 9). More than 70% of the induced
miRNAs in cluster A failed to be induced
after DNA damage in HCT116TP53-/-
cells, including the six induced miRNAs
predicted as direct p53 targets. In cluster
D, the repression was lost for 6 miRNAs
Table 1. Human miRNAs whose expression is signiﬁcantly altered during the DDRgrey
M value
MCF HCT *Differential expression
miRNAs 4 hr 24 hr 4 hr 24 hr MCF10A HCT116 Max(M)
miR-34c-5p 2.37 3.98 0.59 3.54 1 1 3.98
1947411_x4 0.37 0.95 0.59 2.65 1 1 2.65
miR-486-5p Inf Inf 0.58 1.95 1 1 1.95
miR-148a-3p 1.10 1.77 0.71 1.26 1 1 1.77
miR-152 0.33 0.85 0.23 1.76 1 1 1.76
miR-1247-3p NA NA 0.53 1.69 0 1 1.69
miR-1 1.23 0.98 0.77 1.58 1 1 1.58
let-7a-3p 1.55 0.49 0.89 0.50 1 1 1.55
miR-365a-3p 0.91 0.16 0.47 1.43 1 1 1.43
miR-3184-3p 1.10 0.30 0.21 1.39 1 1 1.39
miR-423-5p 1.10 0.30 0.21 1.39 1 1 1.39
miR-139-5p 1.00 ¡1.00 0.40 1.23 0 1 1.23
miR-125b-5p ¡0.54 0.89 1.02 0.87 0 1 1.02
miR-191-5p 0.04 0.29 0.17 0.97 0 1 0.97
miR-34a-5p 0.47 0.77 0.32 0.97 1 1 0.97
miR-96-5p 0.96 0.93 0.51 0.40 1 0 0.96
miR-192-5p 0.18 0.44 0.40 0.93 0 1 0.93
miR-215 0.19 0.46 0.40 0.93 0 1 0.93
miR-148b-3p 0.28 0.26 0.43 0.84 0 1 0.84
miR-146a-5p ¡0.64 ¡0.60 0.16 0.84 0 1 0.84
*Criteria for differential expression is M > 0.75, A > 5, corr p < 0.05; 1, satisﬁed; 0, not satisﬁed.
M values are from the replicate 1.
Figure 6. The distribution pattern of DDR miRNAs. (A) Shows the distribution in the human
genome of loci encoding miRNAs whose expression is altered in response to DNA damage
(DDR miRNAs). Open column represents miRNAs that were not induced by DNA damage. Grey
color ed column include miRNAs that responded to 5Gy ionizing radiation. (B) Pie chart repre-
sents the percentages of miRNAs by the site on the genome. Intragenic single miRNA are
shown in blue, intragenic miRNAs with the cluster in red and intergenic single miRNAs in green,
respectively.
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at 4 h and for 5members of themiR-550 family at 24 h. Among the
seven miRNAs found robustly repressed in HCT116, 3 miRNAs
were found to be p53 dependent (miR-1273a or 825400_x9, miR-
374a and miR-4707-5p) including 2 previously predicted as direct
p53 targets (Fig. 9B). These results suggest that miRNA expression
during the DDR is both directly and indirectly p53-dependent, and
identify several miRNAs as previously unrecognized targets for p53-
dependent regulation.
Discussion
The findings we report here provide a comprehensive descrip-
tion of genome-wide changes in the expression of miRNAs during
the response to DNA breakage in human cells. Previous analyzes
using alternative methods such as miRNA array profiling have
detected a smaller fraction of DDR-regulated human miRNAs
induced by ionising radiation. For instance, 11 DNA damage
responsive miRNAs were detected in dermal fibroblasts, out of
361 tested,31 of which 2 (miR-20a, upregulated; miR-148b,
downregulated) were also detected in our studies albeit with differ-
ing patterns of expression. Changes in the expression of 17 out of
186 miRNAs were detected in primary human fibroblasts exposed
to ionizing radiation,32 of which only 2 (miR-125b and let-7a)
were also found in our analysis. Analysis of several cancer cell lines
detected 29 DDR-regulated miRNAs out of 1100,33 of which we
detected 3 (miR-96, 148b and let-7a). Differences in the cell type
and radiation dose, as well as the lower sensitivity of array-based
methods compared to NGS, may account for these differences.
Figure 7. Annotated network between DDR miRNAs and transcription factors. Sub-network corresponding to the DDR miRNAs and their known regula-
tors annotated in Transmir v1.2. Nodes corresponding to miRNAs are in blue hexagons, nodes corresponding to TFs are in purple circles. Edges are repre-
sented as green arrows from TFs to target miRNAs.
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Our experiments were designed to detect DDR-induced
changes in miRNA expression at 4 h and 24 h after damage
exposure, in 3 different cell types. The choice of time points
reflects published evidence that the activation of gene expres-
sion by transcription factors such as NFkB or p53 induced
after DNA damage occurs within 4–24 h time-scale1; indeed,
similar time points have also been used to study miRNA-
mediated changes after UV-induced damage.13 The cell types
were chosen to facilitate a series of biologically informative
conclusions. Thus, MCF10A is a widely used, non-
transformed mammary epithelial cell line, which retains nor-
mal G1 and G2 cell cycle checkpoints for DNA damage, and
in which ATM activation and p53 induction occur after
DNA damage (Figs. 1A and B). By contrast, HCT116 is a
transformed colorectal carcinoma cell line, for which an oth-
erwise isogenic but p53-negative counterpart has been gener-
ated by gene targeting (Fig. 1B), enabling the role of p53 in
the response to be determined.
Our study design did not include time-point specific control
samples that were not treated with IR; instead, we made
Figure 8. Enrichment plots of microRNA signatures in all miRNAs ranked by TP53 motifs. GSEA pre-ranked results for 2 gene sets (signatures) scored for
enrichment of TP53 binding sites: the DDR miRNAs (in blue) and the TP53 annotated targets as a positive control set (in green). The X-axis represents all
known miRNA genes ranked by the score of TP53 motifs in their regulatory region. Genes with best scores are toward the left. The score distribution is
represented by the gray chart in the background, with corresponding y-axis in the right. The black vertical bars correspond to the ranking of the miRNAs
of the given signature. The curves display the running enrichment score (ES) for the gene set as the analysis walks down the ranked list. The score at the
peak of the plot (the score furthest from 0.0) deﬁnes the ES for the gene set. For each tested set, the number of miRNAs, the normalized enrichment
score (NES) and the FDR q-value are indicated in the legend.
Table 2. Enriched miRNAs as transcriptional targets of p53
Name Rank in gene list Rank metric score Runninges Core enrichment
mir-34a 0 34.82690048 0.19905818 Yes
mir-34c 1 34.6026001 0.3968343 Yes
mir-486 19 18.5720005 0.49173445 Yes
mir-139 32 16.42160034 0.5776527 Yes
let-7a-2 76 12.94890022 0.623206 Yes
mir-125b-1 101 11.50020027 0.67305356 Yes
mir-365a 323 6.691860199 0.5650411 No
mir-215 389 6.109330177 0.556942 No
mir-96 524 5.189610004 0.497921 No
let-7a-1 651 4.54610014 0.44051638 No
mir-423 759 3.868499994 0.39181334 No
mir-1247 789 3.651760101 0.3934929 No
mir-192 872 3.154949903 0.35725677 No
mir-191 877 3.117209911 0.3724264 No
mir-3184 901 3.018699884 0.3744585 No
mir-152 1051 2.350739956 0.2892843 No
mir-1-2 1084 2.201610088 0.2806899 No
mir-148b 1111 2.113770008 0.27556428 No
mir-125b-2 1520 0.065534301 0.005919015 No
let-7a-3 1529 0.00653213 6.62E-04 No
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comparisons with undamaged cells (0 h samples). Moreover, we
have only performed technical replicates of library preparation
and NGS from the same RNA samples, rather than to include
multiple biological replicates at each time point. These proce-
dures might increase the false positive rates.34 However, we have
taken several steps to mitigate problems potentially arising from
biological variance. We irradiated all samples together, and
returned them to the incubator before preparing RNA samples at
4 h and 24 h to minimize differences in manipulation between
samples to the extent possible in this study design. We
sequenced, as noted above, replicate samples of miRNAs from
several different cell lines at different times after exposure to IR.
Finally, we used an independent method, qPCR, to assess
changes in the expression of DDR-regulated miRNAs in
Figure 9. TP53 shapes genome-wide patterns of human miRNA expression during the DNA damage response. (A) Shows the heat map of expression pat-
terns for 93 DDR-responsive miRNAs in HCT116 and HCT116TP53-/- cells at 4 h and 24 h after DNA damage, compared to their expression at 0 h. Two
technical replicates (1 and 2) were analyzed for each condition. Each row represents a speciﬁc miRNA species. miRNAs were clustered by the pattern of
the expression into clusters as in Fig. 5. (B) Shows changes in the expression of cluster A (miRNAs induced during the DDR) and cluster D (miRNAs
repressed during the DDR). Note that the induction of cluster A miRNAs is lost in HCT116TP53-/- cells, but not the repression of those in cluster D.
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biological replicate samples. Collectively, these steps provide an
additional layer of controls to account for biological variance.
Our work demonstrates that complex and strongly cell-type
dependent patterns of altered miRNA expression occur after the
exposure of cells to DNA damage. This suggests that alterations
in miRNA form an essential regulatory component during the
DDR. For example, previous studies have shown that the miR-
34 family is induced by DNA damage, and suppresses the expres-
sion of genes such as CDK4, CDK6 and cyclin E, regulating cell
cycle arrest after DNA damage.7 Notably, many miRNAs
detected in our work are induced >4–24 h after damage, sug-
gesting that their turnover may coordinate essential changes in
gene expression required for the DDR over a relatively long time
period.35 Thus, our findings provide a genomic resource for
future biological studies to uncover new participants and mecha-
nisms in the human DDR, which operate not only during the
acute phase of the response, but also during cell recovery.
However, the strongly cell-type dependent patterns of
miRNA expression detected in our work emphasizes an
important issue that such future studies must be mindful of.
We observe that hardly any miRNAs are commonly regulated
in the different cell lines used here, even in the 2 TP53 wild-
type epithelial cell lines MCF-10A and HCT116. Given that
different cell types derived from different tissues show clear
differences in sensitivity to IR and the dynamics of the
DDR, likely through differential use of DDR signaling and
DNA repair pathways,36 our findings caution that each cell
type may regulate an individual subset of miRNAs during
the DDR.37 This could make it difficult in future studies to
compare or extrapolate the physiological role of DNA dam-
age-responsive miRNAs between different cell types.
Several miRNAs detected in our analysis as being induced
after DNA damage exhibit lower expression in different forms of
epithelial cancer. For example, miR-125b expression is decreased
in breast cancer,38 miR-148b, in gastric cancer39; miR-148a and
miR-30a-5p, in colorectal cancer40,41; and miR-96, miR-143/
145, and miR-34a, in pancreatic cancers.42,43,44 This correlation
prompts us to speculate that these miRNAs may act as tumor
suppressors, whose induction is normally part of the DDR, but is
lost during carcinogenesis to induce genome instability. Further
studies to address this hypothesis are warranted.
We were able to analyze if the DDR miRNA expression levels
in tumor samples predict clinical outcomes in patients using
MIRUMIR, a webserver that performs survival analyzes across
several available data sets.45 Around half of the DDR miRNAs
exhibited a significant association between their expression levels
and patient survival (Chi-squared corrected p-value < 0.05) in
cancers of the prostate, breast and nasopharynx. These include
24 miRNAs out of the 51 DDR-induced miRNAs in HCT116
(Cluster A in Fig. 5), 1 out of 4 DDR miRNAs from Cluster B,
2 out of 4 miRNAs from Cluster C, and 6 out of 10 DDR miR-
NAs from Cluster D (Supplementary Table S2). Also, 2 out of 4
predicted direct targets of p53 - miR-34a and miR-215 — are
also significantly associated with patient survival (Fig. S4). The
majority of these associations (37/50) linked low expression of
the DDR miRNAs with poor clinical outcome. However, in few
cases (let-7a*, miR-33b, miR-34a, mir-143, miR-423, miR-486,
miR-92a, miR-484), a high level of miRNA expression was asso-
ciated with poor outcome, but in a different cancer type. For
example, low expression levels of miR-34a, one of the predicted
direct targets of p53, are associated with poor outcome in breast
cancer (p-value D 0.0009), while high expression levels are asso-
ciated with a poor outcome in ovarian carcinoma and hepatocel-
lular carcinoma (p-values D 0.049) (Fig. S4). These results
emphasize that tissues-specific patterns of DDR-induced miRNA
expression may provide prognostic markers for patients with
cancer.
Our findings reveal a major biological function for the p53
tumor suppressor in regulating the induction of miRNA expres-
sion following DNA damage. In particular, we find that 51
DDR-miRNAs (represented by cluster A in Fig. 9B) were
induced at 24 h in HCT116 cells but not in their TP53-/- but
otherwise isogenic counterparts. It has been proposed that p53 is
involved in miRNA biogenesis in conjunction with the Drosha
complex.14 In addition, our analyzes suggest that p53 acts in the
DDR via a transcriptional mechanism, exemplified in the enrich-
ment of p53 consensus binding sites in the regulatory regions of
several DDR miRNAs. This function of p53, along with the pos-
sible roles played by other DDR-induced transcription factors,
deserves attention in future studies. For example, the recent avail-
ability of ‘big’ cancer data sets such as TCGA will make it possi-
ble to interrogate at what level p53 status (mutations, expression,
subtypes) is correlated to its miRNA direct targets, and to patient
survival.
Thus, in conclusion, the work we report here provides a first
outline of genome-wide changes in the expression of miRNAs
during the response of human cells to DNA damage, and reveals
an important biological role for the tumor suppressor p53. We
demonstrate that >10% of all known miRNAs alter their expres-
sion 4–24 h after exposure to radiation, in complex patterns that
strongly depend on cell type. Binding sites for p53 are enriched
in the regulatory regions of the most-highly induced miRNAs,
and genetic ablation of TP53 decreases miRNA induction but
not suppression, during the DDR. The expression levels of cer-
tain DDR-induced miRNAs in tumor samples correlate with
patient outcome. Our findings provide a genomic resource for
future work studying the biological significance of miRNAs that
are induced or repressed after exposure to DNA damage, identi-
fying their targets and the role of their regulation, and elucidating
the function of p53 in the transcription of DDR-induced
miRNAs.
Materials and Methods
Cell culture
MCF10A, a widely used, non-transformed mammary epithe-
lial cell line, which retains normal G1 and G2 cell cycle check-
points for DNA damage, and in which ATM activation and p53
induction occur after DNA damage, was obtained from, and
authenticated by, Cancer Research UK (CRUK) Cell Services.
HCT116 is a transformed colorectal carcinoma cell line, for
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which an otherwise isogenic p53-negative counterpart has been
generated by gene targeting, enabling the role of p53 in the
response to be determined. HCT116 and HCT116 TP53-/- cell
lines were kindly provided by Dr. Bert Vogelstein (Sidney Kim-
mel Comprehensive Cancer Center, Baltimore, MD, USA).
MCF10A cells were grown in Dulbecco’s Modified Eagle’s
medium (DMEM/F-12 (1:1), Invitrogen) supplemented with
5% horse serum, 10 mg/ml insulin, 20 ng/ml EGF, 100 ng/ml
choleratoxin, 500 ng/ml hydrocortisone and 100 U/ml penicillin
and streptomycin. HCT116 and HCT116 TP53-/- cells were
cultured in McCoy’s 5A Medium (Invitrogen) supplemented
with 10% FBS, 100 U/ml penicillin and streptomycin. Cultures
were maintained at 37C and at 5% CO2.
DNA damage treatment
The day before IR treatment, 1.2 £ 106 MCF10A cells or 1.8
£ 106 HCT116 and HCT116 TP53-/- cells were plated in
9.2 cm dishes. Five Gy of IR was administered using the
43855D Faxitron Cabinet X-ray System, followed by incubation
for 4 or 24 hour at 37C in 5% CO2 before harvesting.
Western blotting
Cells were harvested with trypsin and collected by centrifuga-
tion in the presence of growth media before washing in phos-
phate buffer saline (PBS) washes. Whole-cell extracts were made
in the NP-40 lysis buffer [50 mmol/L HEPES (pH D 7.4),
100 mmol/L NaCl, 0.5% NP-40, 10 mmol/L EDTA,
20 mmol/L b-glycerophosphate, 1 mmol/L DTT, 1 mmol/L
sodium orthovanadate, 1 mmol/L PMSF (phenylmethylsulfonyl-
fluoride), complete protease inhibitor cocktail (Roche, Burgess
Hill, UK)]. Samples were resolved with NuPAGE Novex 4–12%
Bis-Tris gels (Invitrogen, Paisley, UK). Western blot detection
with the listed antibodies was visualized with horseradish peroxi-
dase (HRP)-coupled secondary antibody and an enhanced
chemiluminescence kit (Amersham, Bucks, UK). Antibodies
used were: phospho-ATM (Ser1981) (D6H9) Rabbit mAb (Cell
signaling #5883) at 1:500; anti-b-actin (A5441, Sigma) at
1:5000; anti-p53 (sc-126, DO-1, Santa Cruz, CA, USA) at
1:1000; phospho-p53 (Ser15) (16G8) Mouse mAb (Cell signal-
ing #9286) at 1:500.
Total RNA extraction
Cells were rinsed once with 1xPBS, and lysed in 3 ml of Tri-
zol reagent (Invitrogen, Carlsbad, CA, USA). RNA extraction
was carried out according to the manufacturer’s instructions. The
concentration of purified total RNAs was adjusted to 1 &g/&l
with RNase free water. RNA was extracted once from each of the
3 cell lines (MCF10A, HCT116 and HCT116 p53-/-) at 0 h,
4 h or 24 h after DNA damage. Small RNA (18–30 nt) purified
from these samples by gel electrophoresis was independently ana-
lyzed twice using RNA sequencing. All analyzes using qPCR for
miRNA expression were performed using at least 3 independent
biological replicates without small RNA fractionation.
Generation of the small RNA library for NGS
Ten mg of total RNA was subjected to 15% TBE-urea PAGE
before small RNA species between 18–30 nt in length were excised
and eluted in 0.3 M NaCl. The v1.5 small RNA 30 adapter (Illu-
mina) was ligated using T4 RNA ligase 2, truncated (NEB), and
then the small RNA 50 adapter was ligated using T4 RNA ligase.
Reverse transcription was performed using the small RNA RT
primer (Illumina) using the 50 and 30 adapter-ligated RNAs as a
template. Twelve cycles of PCR amplification were carried out
using GX1 and GX2 primers with Phusion DNA polymerase. The
amplified cDNA preparation was subjected to 6% TBE PAGE,
and species of »100 bp were excised and purified. Finally, each
cDNA library was validated with an Agilent bioanalyzer using the
DNA 1000 kits to confirm size, purity, and concentrations. Each
library was sequenced in 2 lanes on the Illumina Genome Analyzer
IIx using a single-read and 36 sequencing cycles. Raw data are
available from the NCBI Gene Expression Omnibus (GEO) repos-
itory (accession number GSE50064) and the reviewers can access
the data through this reviewer access link http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?tokenDfjsvtqsieeqiahi&accDGSE50064.
Quantitative reverse transcription (qRT)-PCR
The total RNA (10 mg) was treated with DNase I (Promega)
followed by polyadenylated using Poly(A) polymerase (NewEng-
land BioLab) according to the manufacturer’s instructions, phenol:
chloroform extracted, ethanol-precipitated, and dissolved in
RNase-free water at 1 mg/ml. A modified cDNA was made as fol-
lows: 10 mg of polyadenylated RNA was reverse-transcribed using
Superscript II reverse transcriptase (Invitrogen) with 2.5 mg of
random hexamers (Qiagen) and 500 ng of oligo(dT) adapter
primer (50-GCGAGCACAG AATTAATACGACTCACTA-
TAGGTTTTTTTTTTTTVN-30). The reaction was terminated
by incubation at 70C for 10 min and diluted into 2 mL of dH2O
(5 mg/mL). Quantitative PCR was used to measure the mature
miRNA as follows: 10 mL of 2 £ LightCycler 480 SYBR Green I
Master (Roche) was mixed with 5 p.m.ol of both the forward and
reverse primers in a volume of 15 mL and 5 mL of cDNA was
added in a final volume of 20 mL. Basically, each forward primer
has each microRNA specific sequences and the reverse primer was
universal for all the cDNA from microRNAs and the sequence was
Uni-R, 50-GCGAGCACAGAATTAATACGACTCAC-30. All
reactions were run in triplicate on LightCycler 480 (Roche) using
a PCR condition for 5 min at 95C, 10 sec at 95C 10 sec at
56C, 10 sec at 72C, for 45 cycles. A reference gene, SNORD48
small nucleolar RNA, C/D box 48 (RNU48-F, 50-
GTGTCGCTGATGCCATCAC-30; RNU48-R, as same as the
universal reverse primer) was used to confirm the similar amount
of small RNA in different samples. Expression levels were calcu-
lated using the “Second Derivative Maximum Method” according
to software provided for the Light Cycler 480 (Roche) to quantitate
DDRmiRNAs or the control RNU48.
Detection of known miRNA species
Nine libraries of »12 million reads each were generated in
duplicate from next-generation sequencing of small RNA
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samples. Adapters were trimmed from sequencing reads. Reads of
length <18 nt after adapter trimming and with low complexity
(polyN) were excluded from further analyzes. The remaining
reads were mapped to the human genome (Hg18) using Bowtie46
with the default parameters (seed length of 28, maximum num-
ber of 2 mismatches, and report up to 1 alignment per read).
Reads mapping the reference genome were then aligned to
known miRNAs (miRBase version 18, release 11/201147) using
BLAST,48 where 100% identity between reads and known
miRNAs sequences was required. To detect other known small
RNAs, the mapped reads were also aligned with BLAST against
the non-coding RNAs extracted from the UCSC Table Browser
[PMID:11081512,PMID:11914277]. A weight of 1 was added
to miRNA when no reads was detected in a given sample.
miRNAs with an aggregate count of less than 100 in all 16 sam-
ples were eliminated; then the total read count for each lane was
scaled relative to the library size (total number of reads that
mapped to known miRNAs). Read counts of technical replicates
were then merged, and log2 (fold change) values were calculated
for each miRNA. P-values were subsequently calculated using a
binomial approximation to Fisher’s exact test for each miRNA.
New microRNA predictions
New miRNA were predicted using MIReNA version 2.0, a
genome-wide search algorithm designed for the discovery of new
microRNAs from deep sequencing data (Mathelier and Carbone
2010). The algorithm was used with default parameters (using
option–-blast to perform the blast search of deep sequencing
reads on the Human genome Hg18, and option–-miRNAs with
the conserved mature miRNAs sequences). All filtered reads were
merged in one input file and reads with only one sequencing
count were discarded for this step.
Differential expression analysis
Counts for known miRNAs were calculated as the sum of the
reads matching to the miRNA. 308 Predicted miRNAs were
added. A threshold on the aggregate count (100) was used to dis-
card low expressed miRNAs over the 18 sequenced samples, leav-
ing 965 miRNAs (including 125 new miRNAs). Then, the total
read count for each lane was scaled relative to the library size.
The significance of the differential expression was calculated for
each miRNA using the Fisher test function from R stats package.
P-values were corrected for multi-testing (total number of
miRNA tested). We used less stringent thresholds to filter the
DDR new miRNAs: |log2 (fold change)| >0.5, log2 (average
read counts) >4, and significance (p < 0.001) in at least one out
of 4 conditions (MCF10A 4 and 24 hours, HCT116 4 and
24 hours, compared to their respective control). All data analysis
was done using R (R Development Core Team, 2011).
Filtering for the most-highly regulated DDR miRNAs
The initial list of DDR miRNAs corresponded to known and
new miRNAs, which show significant differential expression at
least once over all comparisons and different replicates. This led
us to a list of 150 miRNAs. To get the most robust predictions
we applied additional filters: 1) the fold change of the miRNAs
should show a similar trend at 4 h and 24 h, 2) the fold change
at 4 h or 24 h should be significant (multi-testing corrected p
value < 0.05), and 3) miRNAs should be significantly induced
in 2 cell lines or/and in 2 replicates. This filtering detected 23
induced DDR miRNAs (including one new miRNA). Three of
the DDR miRNAs were discarded as they correspond to different
species of the same miRNA. We kept the mature sequences that
may represent the functional species (miR-139-5p, miR-486-5p)
instead of the star sequences (miR-139-3p, miR-486-3p). The
mature sequences of miR-365a-3p and miR-365b-3p are exactly
the same, while our differential expression analysis does not take
the mapping position of the reads into account and thus does not
allow us to distinguish the right species. Note that we kept the
mature sequences of miR-148a-3p and miR-148b-3p as they
differ from 2 nucleotides, idem for miR-34a-5p and miR-34c-5p
(4 mismatches, 1 insert).
p53 motif enrichment
We used known p53 motifs to detect homotypic cis-regulatory
modules (CRMs) in the putative regulatory regions of human
miRNAs using the Cluster-Buster v1.5 CRM-scanning tool [1].
We delineated miRNA promoter regions to cover the genomic
regions [¡5 kb,+500 bp] in relation to the start of single or clus-
tered intergenic miRNAs, [¡4 kb,+2 kb] to the transcription
start sites of host genes for intragenic miRNAs, and
[¡3.5 kb,¡500 bp] to the start of single or clustered intragenic
miRNAs. We defined a miRNA as being intragenic if it was
located within an annotated transcript from the same strand
(host gene). From 1523 annotated miRNAs in miRBase v18 [2],
we extracted 383 intergenic features (30 clusters and 353 single
miRNAs) and 2766 intragenic features (388 clusters and 2378
single miRNAs). Seven annotated Position Weight Matrices
(PWMs) corresponding to p53 binding were collected from
Jaspar core database49 and TRANSFAC Professional Release,50
[license number] (transfac_pro-M01655, transfac_pro-M01652,
transfac_pro-M00272, transfac_pro-M01651, transfac_pro-
M00761, transfac_pro-M00034 and jaspar-MA0106.1). The
miRNA regulatory regions were scored for p53 homotypic
CRMs using cluster-buster (using –c0, setting the cluster thresh-
old to zero, in order to score all regions). The maximum score
for each miRNA was used to rank them in a given species. To
benefit from the conservation of regulation, putative orthologous
regulatory regions in 10 related species were deduced using the
UCSC LiftOver standalone program, as described before for
cisTarget.51 In total, we scored the miRNAs in 10 vertebrate
species: Bos taurus (bosTau4), Canis familiaris (canFam2), Homo
sapiens (hg19), Mus musculus (mm9), Monodelphis domestica
(monDom5), Pan troglodytes (panTro2), Pongo abelii (ponAbe2),
Macaca mulatta (rheMac2), Danio rerio (rn4), Sus scrofa
(susScr2). The 10 rankings were integrated into one final q-value
score using rank aggregation by order statistics,51,52 followed by
a minus log transformation producing a final ranking of all
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Human miRNAs. We then applied Gene Set Enrichment Analy-
sis (GSEA)29 on the 3 sets of miRNAs: 20 DDR predicted
miRNAs, 13 TP53 target miRNAs annotated in Transmir
(Transmir set), and 24 curated TP53 target miRNAs (mean div
normalization, default weighted scoring scheme as parameters).
Annotated TF-miRNAs interactions are from TransmiR v1.2 (162
miRNAs, 37 TFs). The curated set corresponds to TP53 sets anno-
tated in Transmir (http://202.38.126.151/hmdd/mirna/tf/),
HMDD (http://202.38.126.151/hmdd/mirna/md/) and from ref
(http://www.ncbi.nlm.nih.gov/pubmed/22110125).
Survival analysis from miRNA expression profiles
MIRUMIR (http://www.bioprofiling.de/GEO/MIRUMIR/
mirumir.html) was queried online to test whether each DDR
microRNA could predict survival across multiple available data
sets covering 7 cancer types: breast cancer (GSE37405,
GSE22216, GSE19783), prostate cancer (GSE21036), nasopha-
ryngeal carcinoma (GSE36682), ovarian carcinoma
(GSE27290), hepatocellular carcinoma (GSE10694), esophageal
adenocarcinoma or squamous cell carcinoma (GSE13937) and
lung cancer (GSE16025). For each available data set, samples
were split into 2 groups, with high or low microRNA expression.
MIRUMIR provides Kaplan-Meier (KM) plots along with Cox
regression survival analyzes.
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